Immunoblot Blocking Reagent from Upstate
Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Amido Black 10B, CI 20470 from Research Organics, Inc.
Anti-Acid Phosphatase, Potato Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products:...in German . , Halle/Saale. For the first time i...of which alien species are present in Europe, thei... society. More than 11,000 alien species have been...pecies Inventory for Europe), a unique three year ...tists, funded by the European Union that provides ...
...e system hates strangers. When its security patrol...is the problem when people with type 1 diabetes un...cells from a donor pancreas produce robust amounts...independence from insulin therapy. However, the im...ets. , A person who has the transplant procedure ...
...ating an ageing population, and turning research i... 20 million ($30.4 million) investment announced t...arch Council (EPSRC), Technology Strategy Board (T...Research Council (BBSRC). , This new investment w...ass scientific breakthroughs have already been ach...
Other Biology News:11,000 alien species invade Europe 2New technique eliminates toxic drugs in islet transplant in diabetic mice 2£20 million to fight virtual crime and treat our ageing population 2£20 million to fight virtual crime and treat our ageing population 3(Date:12/2/2009)...wire-USNewswire/ -- Nearly 600 medical research ex...oday convened to explore novel development approac...ural Partnering for Cures meeting. ,, Faste... Institute, convened Partnering for Cures to fac... a scientific discovery into an accessible therapy...
(Date:12/2/2009)...ecember 2 , - "Bolstering...ritage" , Coinciding with the Internation...e Republic is hosting an international conference ... biological resources in Africa. The,conference wi...nisters,scientific experts, private companies, re...
(Date:12/2/2009)...PRNewswire/ -- S*BIO Pte Ltd today announced data ...1518, at The American Society of Hematology 51st A... Data will be presented on the clinical results fr...ailing its safety, tolerability and pharmacokineti...anging from 100 to 600 mg. These doses were admini...
(Date:12/2/2009)...PRNewswire-Asia/ -- The world is going through,ext...tainty is part of many,businesses and industries. ...atively immune to the economic downturn, because i...the midst of the difficult times this year, the ph...ed an R&D center in Shanghai, the largest of,i...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3